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SUMMARY 
The insertion of two lysine residues (cleavage sites of cathepsin B) at the boundary 
of a peptide recognized by B cells (BD) and a class-Ii- presentable sequence (TD,) en- 
hanced the anti-BD antibody induction capacity of this type of peptide construct, as 
well as production of IL2. It is postulated that these lysines generate a neoprocessable 
site which helps in release of the TD, moiety from the construct, enabling its presen- 
tation to class II molecules, an essential step in clonal expansion of the antibody- 
producing B cell after internalization of the construct via the BD moiety. 
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INTRODUCTION 
Immunization experiments with peptide 
chimeras, consisting of a B-cell epitope (BD) co- 
linearly linked to a class-II-presentable T helper 
peptide (TD,), have shown that the immunoge- 
nicity of the construct and the specificity of the 
antibody response induced are dependent on the 
relative positions of the BD and TD,, in the 
chimera (Cox et a/., 1988; Levely et al., 1990; 
Golvano et al., 1991). These differences in 
response may be due to changes in the process- 
ing and/or structure of these constructs. 
Becduse pairs of basic residues (KK, KR, RR) 
are the main cleavage sites of cathepsin B, one 
of the most important enzymes for antigen 
processing in the context of class II molecules 
(Takahashi et al., 1989), we speculated that the 
insertion of a pair of lysine residues at the 
boundary of the BD and TD, moieties of a 
poorly immunogenic BD-TD, construct might 
improve the immunogenecity of this construct. 
Moreover, an insight into the effect of surface 
exposure of the moieties upon the specificity of 
the antibodies induced might be obtained by 
measuring the recognition of the chimeras by 
anti-BD and anti-TD,, antibodies. The results of 
these experiments are shown below. 
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MATERIALS AND METHODS plates were read at 405 nm in a “Titertek Multiskan” 
MKII (Flow laboratories). Endpoint antibody titres 
Peptide synthesis 
were expressed as the highest dilution giving 3 times 
the optical density of the preimmune serum. 
Peptides were synthesized by the solid phase 
method of Merrifield (Merrifield, 1963) using the 
Fmoc alternative (Atherton ef al., 1981). Synthesis 
was carried out manually and the ninhydrin test of 
Kaiser (Kaiser el al., 1970) used to monitor every 
step. Couplings were repeated if necessary until a 
negative ninhydrin test was attained. All peptides 
were purified by HPLC (high performance liquid 
chromatography) on a reverse phase Cl8 column. 
Immunization experiments 
Groups of three 4-week-old BALB/c female mice 
were immunized by i.p. injection of 200 ~1 of an 
emulsion obtained by sonication of 100 PI of com- 
plete Freund’s adjuvant and 100 yl of saline solution 
containing 60 pg of peptide antigen, and boosted at 
days 30 and 45 with the same dose of antigen in in- 
complete Freund’s adjuvant. Mice were bled from 
the orbital sinus on days 30, 45, and 60 after the first 
injection. 
Titration of antibodies 
Anti-peptide antibodies were titrated by ELISA 
as described (Golvano ef al., 1990). Basically, 
microtitre wells (Nunc, Denmark) were coated with 
peptides by incubation with 50 ~1 of peptide solutions 
at 4°C overnight (20 Kg/ml of peptide in 0.1 M sodi- 
um carbonate buffer, pH 10.5). The wells were 
washed with phosphate buffer saline, pH 7.6 con- 
taining 1 % powdered milk and 0.1 Vo Tween 20 
(PBSMT), and incubated with this buffer for 1 h at 
room temperature to block non-specific antibody 
binding. After removing the PBSMT, 50 ~1 of differ- 
ent serum dilutions were added and incubated at 
37°C for 1 h (for the peptide inhibition experiments, 
the serum was pre incubated with peptide at 37°C 
for 1 h). Following the addition of goat anti-mouse 
IgG biotinylated whole antibody (Amersham, UK) 
and horseradish peroxidase-streptavidin (Amersham, 
UK), the colour reaction was started by adding 
40 mM of ABTS (2,2’-azino-bis(3-ethylbenz- 
thiazoline-6-sulphonic acid) in water. After 30 min, 
IL2 production assay 
Mice were immunized at the base of the tail and 
footpads with peptide (100 pg/mouse) in complete 
Freund’s adjuvant (1: 1). Ten days after the primary 
injection, animals were killed and lymph node cells 
were removed. The lymphocytes were then plated on 
96-well plates (Costar) at 5 x 10’ cells/well with 
RPMI-supplemented medium (RPM1 supplemented 
with 10 % foetal calf serum, 10 mM glutamine, 
penicillin 100 U/ml, streptomycin 100 mg/ml and 
5 x 10e5 M 2-mercaptoethanol) or serial dilutions of 
peptides in 0.2 ml final volume. Supernatants (50 ~1) 
were removed 24 h later and assayed for the IL2 con- 
tent as described (Lai ef al., 1987). Results are 
presented as a stimulation index, which is the ratio 
of the mean (three determinations) cpm incorporat- 
ed in the presence of antigen to the mean (three de- 
terminations) cpm obtained in the absence of antigen. 
RESIJLTS 
Humoral immune response 
It has been shown (Golvano et al., 1990) that 
the immunogenicity of peptide constructs 
FISEAIIHVLHSRLKCNNKTFNGTGPCTNV 
(FIS-LKC) and LKCNNKTFNGTGPCTNVF- 
ISEAIIHVLHSR (LKC-FIS) depends on the 
relative orientation of LKC and FIS. These two 
moieties are from HIV1 envelope protein (Wain- 
Hobson et al., 1985) and sperm whale my- 
oglobin, respectively. LKC has a haptenic 
character (Golvano et al., 1990), whereas FIS is 
a TD, in BALB/c mice (Cease ef al., 1986). The 
construct FIS-LKC induced high antibody titres 
against LKC and none against FIS, whereas the 
construct LKC-FIS was much less immunogen- 
ic and gave low antibody titres against both LKC 
and FIS. 
ABTS = Z,Z’-azino-bis(3-ethylbenz-thiazoline-6-sulphonic ELISA = enzyme-linked immunosorbant assay. 
acid). IL2 = interleukin-2. 
BD = B determinant. -4 = T  determinant (helper). 
wm = counts per minute. 
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To test whether the immunogenicity of pep- 
tide LKC-FIS might be enhanced by insertion 
of a cathepsin B cleavage site between the B-cell 
and T-cell epitopes, we synthesized the peptide 
LKCNNKTFNGTGPCTNVKKFISEAIIHVL- 
HSR (LKC-KK-FIS) which contains two extra 
lysines (in bold). This peptide was used to im- 
munize BALB/c mice in order to compare its 
immunogenicity with that of LKC-FIS and 
FIS-LKC. 
The antibody titres at day 60 induced by FIS- 
LKC, LKC-FIS and LKC-KK-FIS were meas- 
ured by ELISA against the whole antigens and 
against the FIS and LKC moieties (table I). With 
the exception of FIS-LKC, which induced anti- 
bodies against the LKC moiety only, the con- 
structs LKC-FIS and LKC-KK-FIS induced 
antibodies against both moieties. Titration of 
anti-LKC antibodies using LKC adsorbed on the 
ELISA plate showed that constructs FIS-LKC, 
LKC-KK-FIS and LKC-FIS induced anti-LKC 
antibodies with titres of 250,000, 85,000 and 
2,400 respectively. These results show that the 
insertion of two lysine residues at the boundary 
between LKC and FIS (to give LKC-KK- 
FIS)dramatically improved the induction of anti- 
LKC antibodies compared to those induced by 
unmodified LKC-FIS. 
Titration of anti-FIS antibodies was done us- 
ing FIS adsorbed on the ELISA plate. FIS-LKC 
did not induce anti-FIS antibodies, whereas 
LKC-KK-FIS induced high anti-FIS titres. 
Accessibility of peptide moieties to antibody 
recognition 
The degree of “accessibility” of LKC and FIS 
in constructs FIS-LKC, LKC-FIS and LKC-KK- 
FIS to antibody recognition was measured by 
titrating anti-FIS antibodies (induced by free 
FIS) and anti-LKC antibodies (induced by FER- 
LKC) (Golvano et al., 1990) against these three 
constructs adsorbed on the ELISA plate (ta- 
ble II). These titrations showed that FIS is poorly 
exposed for antibody recognition in FIS-LKC 
and well exposed in LKC-FIS and LKC-KK-FIS. 
Also, the LKC moiety is well exposed in FIS- 
LKC and less well exposed in LKC-FIS and 
LKC-KK-FIS. 




self FIS LKC 
FIS-LKC 500 0 250 
LKC-FIS 70 2.6 2.4 
LKC-KK-FIS 900 170 85 
(*) Titres shown are means from three different mice. 
Titrations were carried out against self (the whole immuno- 
gen) and against FIS and LKC. 
Table II. Recognition antibody titres (*) (x 10e3) of 
FIS and LKC in three different peptide constructs 
by antisera specific for each of these moieties. 
Peptide Recognition by antibodies 
antigen anti-FE anti-LKC 
FIS-LKC 1.1 43 
LKC-FIS 53 11 
LKC-KK-FIS 80 5 
(*) Titres shown are means from three different mice. 
Ami-FIS and ami-LKC antibodies were induced with free FIS 
and FER-LKC, respectively. 
The degree of accessibility of FIS in the differ- 
ent peptide constructs was also measured using 
a competition assay in solution. Thus, solutions 
of FIS, LKC-FIS, FIS-LKC or LKC-KK-FIS 
were incubated with an anti-FIS antiserum and 
we measured the recognition of FIS adsorbed on 
the plate (table III). These experiments showed 
that FIS-LKC is the sole peptide that is unable 
to inhibit this recognition, proving that FIS in 
FIS-LKC is the least accessible for antibody 
recognition. This result is in agreement with 
those obtained by direct recognition of FIS from 
the different peptide constructs adsorbed on the 
ELISA plate, shown in table II. 
Antigen processing 
To gain an insight into how antigen- 
presenting cells process peptide constructs LKC- 
FIS, FIS-LKC and LKC-KK-FIS, we immunized 
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BALB/c mice with free FIS as described in 
Materials and Methods. After removal of the 
lymph nodes and plating of the lymphocytes, 
these were restimulated with different concen- 
tratiops of FIS, LKC-FIS, FIS-LKC, LKC-KK- 
FIS and without peptide for 24 h. The IL2 con- 
tent of these media was then measured as 
described (Lai et al., 1987). Figure 1 shows that 
the higher levels of IL2 were induced by LKC- 
KK-FIS followed by FIS-LKC, LKC-FIS and 
FIS. 
DISCUSSION 
Three important events define the humoral 
response to an antigen : (1) recognition of epi- 
Table III. Inhibition (olo) of an anti-FIS antiserum 
(l/300) with FIS-containing peptides. 
Peptides (25 pg/ml) 070 Inhibition 













+ FIS-LKC I 
- LKC-FIS 
- LKC-KK-FIS 
Peptide concentration (pg/mI) 
Fig. 1. IL2 production by FIS-immunized BALB/c mice 
after in vifro restimulation of lymph node cells with the 
immunogens shown. 
topes at the surface of the antigen by im- 
munoglobulins of B cells, (2) processing of the 
antigen by the antigen-presenting cell, to free a 
TD, moiety and enable its binding to class II 
molecules and (3) recognition of the complex 
TD,,-class-11 molecules by the T-cell receptor of 
a T helper lymphocyte. From previous work, it 
was know (Golvano et al., 1990) that the out- 
come of immunization with peptide constructs 
FIS-LKC and LKC-FIS was markedly different, 
both with respect to the immunogenicity of these 
peptides and to the specificity of the antibodies 
induced. We speculated that the immunogenic- 
ity of LKC-FIS might be enhanced by inserting 
a cleavage site between the LKC and FIS moie- 
ties. Thus, we synthesized Fhe peptide LKC-KK- 
FIS, which contains a pajr of lysines (in bold) 
that are a cleavage site of cathepsin B, an im- 
portant enzyme responsibje for antigen process- 
ing in the context of class II molecules 
(Takahashi et al., 1989). Antibody induction and 
IL2 production experiments with these three pep- 
tides were carried out to study the outcome of 
the immune response. Using antibodies specific 
for LKC and FIS, we were able to gain an in- 
sight into the accessibility of these moieties to 
antibody recognition in the three immunogens, 
and correlate this accessibility with the humoral 
response. These results are discussed below in 
more detail. 
Antibody response after immunization with en- 
gineered peptide constructs 
The construct FIS-LKC induced high anti- 
bpdy titres against LKC and none against FIS. 
The absence of anti-FIS antibodies may be ex- 
plained by assuming that FIS is “hidden” for 
aptibody recognition in FIS-LKC. Indeed, as 
@own in table II, anti-FIS antibodies recognize 
FIS-LKC poorly, in cor$rast with the recogni- 
tion of LKC-FIS a@ of LKC-KK-FIS. 
Moreover, FIS-LKC is well recognized by anti- 
(FER-LKC), proving that the low titre of anti- 
FIS antibodies, measured against FIS-LKC, is 
not due to poor binding of FIS-LKC to the ELI- 
SA plate. Thus, in FIS-LKC, the FIS moirty is 
poorly accessible to antibodies, whereas the LKC 
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moiety is well presented for antibody recogni- 
tion. Internalization of FIS-LKC via the LKC 
may enable easy processing of the construct to 
free FIS for binding to class II molecuIes. 
The low anti-LKC and anti-FIS antibody 
titres induced by LKC-FIS (table I) may be due 
to poor processing of LKC-FIS after internali- 
zation (either via the LKC or FIS moieties) to 
give available FIS for binding to class II 
molecules. Since, in LKC-FIS, the antibody titres 
against the whole antigen are much higher than 
against the FIS and LKC moieties (table I), we 
favour the hypothesis that LKC-FIS is recog- 
nized and internalized preferentially via one or 
more epitopes simultaneously encompassing 
parts of LKC and FIS. The titre against the 
whole antigen LKC-FIS is much lower than the 
corresponding titres induced by FIS-LKC and 
LKC-KK-FIS. Since antibodies against LKC and 
FIS were induced after immunization with LKC- 
FIS, both moieties are also accessible for anti- 
body recognition. This is confirmed by results 
of table II, which show that they are recognized 
by the corresponding antibodies. 
The construct LKC-KK-FIS induced antibod- 
ies against LKC and FIS with titres of 85,000 
and 170,000 respectively. This shows that LKC 
and FIS are surface-exposed, as confirmed by 
the ability of anti-FIS and anti-LKC antibodies 
to recognize LKC-KK-FIS (table II). 
Processing of peptides by the antigen-presenting 
cells 
The results of IL2 production shown in figure 
1 provide an insight into how FIS is visualized 
following processing of FIS-LKC, LKC-FIS and 
LKC-KK-FIS by antigen-presenting cells. LKC- 
KK-FIS and FIS-LKC induced higher levels of 
IL2, followed by LKC-FIS and FIS. The find- 
ing that LKC-KK-FIS induced higher levels of 
IL2 than LKC-FIS suggests that LKC-KK-FIS 
is better processed than LKC-FIS, in agreement 
with our original hypothesis that insertion of a 
putative cathepsin B cleavage site between the 
hapten and the TD, moiety might enhance the 
immunogenicity of the peptide. The two lysines 
may render this construct more immunogenic 
than LKC-FIS due to improved processing of 
LKC-KK-FIS to liberate FIS for class II bind- 
ing. However, since cathepsin B may not be the 
sole relevant enzyme in class II processing, it can- 
not be excluded that this improved processing 
may be related to other enzymes. Moreover, the 
increase in immunogenicity may also be partly 
due to the structural change induced by the two 
added lysines, which may render both moieties 
(FIS and LKC) more accessible to antibody 
recognition. 
The levels of IL2 after restimulation with free 
FIS were unexpectedly low, especially when con- 
sidering that the mice had been immunized with 
free FIS. A tentative explanation may be that, 
after internalization of FIS by an immunoglobu- 
Iin, FIS may not be efficiently released for bind- 
ing to class II molecules, a situation that has been 
described for other antigens (Ozaki and Ber- 
zofsky, 1987; Manta et al., 1988). However, the 
internalization of constructs FIS-LKC, LKC- 
KK-FIS and LKC-FIS may take place via the 
LKC moiety, leaving FIS more accessible for 
processing. If a “cleavable” site between FIS and 
LKC exists, then FIS might bind more efficiently 
to newly synthesized class II molecules inside the 
cell than to empty class II molecules exposed at 
the surface of the antigen-presenting cells 
(Neefjes and Ploegh, 1992). 
In conclusion, the insertion of a cathepsin B 
cleavage site between the BD and TD, moieties 
of a peptide construct BD-TD, dramatically en- 
hanced the immunogenicity of the peptide. This 
suggests that improved processing may be related 
to enhanced immunogenicity. This strategy may 
prove useful for the design of peptide vaccines. 
Our results demonstrate the role of surface 
exposure (as measured by antibody accessibili- 
ty) of the BD and the TD, epitopes of peptide 
constructs in the outcome of specificity of the 
induced antibodies. We suggest that when 
repeated immunizations of the same animal or 
individual are to be carried out, the idea1 con- 
struct should have the TD, hidden from anti- 
body recognition to avoid induction of 
anti-TD,, antibodies. This would ensure the ab- 
sence of competition for the antigen between the 
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populations of B lymphocytes specific for the 
BD and TD, moieties respectively. Thus, the 
desired anti-BD antibodies would be preferen- 
tially induced. 
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Augmentation de I’immunogCnicittS 
d’un peptide par insertion d’un site de clivage 
de la cathepsine B entre les dkterminants 
reconnus par les lymphocytes B et T 
L’insertion de 2 residus lysine (sites de clivage de 
la cathepsine B) a la front&e d’un peptide reconnu 
par les cellules B (BD = B determinant) et d’une 
sequence ((presentable)) de classe I1 (TD,, = T deter- 
minant helper), augmente la capacite pour ce type 
de construction peptidique d’induire des anticorps 
anti-BD ainsi que la production d’IL2. L’hypothese 
est que ces residus lysine generent un site de neopro- 
cessus qui contribue a la liberation de la moitie TD, 
de la construction, rendant possible sa presentation 
aux molecules de classe II, &ape essentielle pour le 
developpement clonal des lymphocytes B produisant 
des anticorps aprts internalisation de la construction 
via la moitie BD. 
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